|

June 22-25, 2008
Dr. David Lester, Executive VP, Corporate
Development, will be chairing and speaking in a session at the Annual
DIA conference, Boston, MA. His session is on Personalized Medicine. Dr.
Lester will be addressing the need and value of standardization and
validation of molecular diagnostic tests in order to facilitate the
commercial success of such tests and enhancing the potential of
Personalized Medicine as an integral component of Healthcare Delivery.
April 29, 2008
David S. Lester, PhD, Senior VP of Strategy and
Corporate Development speaks out on the future of Pharma.
April 21-23 2008
Larissa G. Karnaoukhova, PhD, Director, Strategic Partnerships West
Coast, will present a report at the 4th Annual Quantitative PCR meeting
entitled: FDA/ICH Analytical Method Validation for Genomic Transcript
Abundance by Standardized Reverse Transcriptase PCR using a Standard
Mixture of Internal Standards. San Diego, CA.
www.healthtech.com
April 12-16 2008
Dr. James C. Willey, Founder and
Chief Science and Medical Consultant, is speaking at the American
Association for Cancer Researchs Annual Meeting in San Diego, CA.
www.aacr.org
March 25-28 2008
David S. Lester, PhD, Senior VP
of Strategy and Corporate Development will be at the Molecular Medicine
Tri-Conference heading up an expert panel on: Putting Personalized
Medicine into Clinical Practice: Perspectives from the Stakeholders. San
Francisco, CA.
www.tri-conference.com
March 25-26 2008
Larissa G. Karnaoukhova, PhD,
Director, Strategic Partnerships West Coast, represents GEI at the
American Association for Clinical Chemistrys San Diego conference:
Genomic Technologies at the Interface of Diagnostics & Therapeutics.
Come visit our booth!
www.aacc.org
March 9-11 2008
David S. Lester, PhD, Senior VP
of Strategy and Corporate Development, is a featured speaker at the
Pharmaceutical Marketing and Research Groups Annual Conference in
Phoenix, AZ.
www.pmrg.org
September 17-20th, 2007
Dr. James
C. Willey, M.D., Founder and Chief Science & Medical Consultant to GEI, will
present an abstract at the annual AACR (American Association for Cancer
Research) Molecular Diagnostics in Cancer Therapeutic Development conference
held in Atlanta, Georgia, September 17-20. The abstract focuses on a
potential biomarker for lung cancer that Dr. Willey and his colleagues at
the University of Toledo have been working on.
|